Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-24

Clinical Trial Update: Influence of Oral Treatment With Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas With Proton Beam Therapy [NA]

View source ↗

Summary

This clinical trial update reports completion of a study evaluating whether oral citicoline can prevent radiation optic neuropathy in patients with uveal melano…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citicoline (CDP-choline)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Uveal Melanoma | NA | Status: COMPLETED